BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Product News   Aug 14, 2017

 
BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Methyltransferases have become a major focus of drug discovery for cancer and other diseases driven by epigenetic factors. BellBrook Labs’ new, ultra-sensitive AptaFluor™ SAH Methyltransferase Assay eliminates cost and sensitivity barriers that are slowing the discovery of methyltransferase inhibitors. Credit: BellBrook Labs

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Vector Laboratories Publishes New Immunohistochemistry Guide

Product News

Vector Laboratories launches comprehensive guide providing helpful tools for understanding and using IHC.

READ MORE

Laboratory Freezers Earn U.S. EPA ENERGY STAR Rating

Product News

Thermo Fisher Scientific expands on their cold-storage products to improve on productivity and sustainability in their laboratories.

READ MORE

Lipid Analysis for Early Stages of Drug Discovery

Product News

Lipotype performed lipid analysis for Flagship VentureLabs with the aim to better understand molecular compositions of chondrisomes.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE